Polyphor AG | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55328	Articles
62458	Press releases

Home
Companies
Polyphor AG

BRIEF

published on 11/05/2024 at 07:20, 16 days 6 hours ago

Spexis Faces Imminent Delisting from SIX Exchange

Delisting Biopharmaceuticals Spexis AG SIX Exchange Financial Suspension
PRESS RELEASE

published on 11/05/2024 at 07:15, 16 days 6 hours ago

Spexis expects SIX to delist shares of Spexis on the SIX exchange imminently.
Spexis AG expects its shares to be delisted from the SIX exchange due to a continuous three-month trading suspension. The company is focused on macrocycle therapeutics for rare diseases and oncology

Switzerland Delisting Spexis AG SIX Exchange Macrocycle Therapeutics
BRIEF

published on 07/29/2024 at 07:20, 3 months 23 days ago

Spexis Granted Definitive Moratorium Status Until November 2024

Fundraising Biopharmaceutical Bankruptcy Spexis Moratorium
PRESS RELEASE

published on 07/29/2024 at 07:15, 3 months 23 days ago

Spexis granted definitive moratorium status until 25 November 2024, subject to monthly progress report obligations, and which can be potentially extended at the request of the administrators.
Spexis AG granted definitive moratorium status until 25 November 2024 by Basel-Landschaft West court, with monthly progress report obligations & potential extension. CEO Jeff Wager comments on the court decision

Spexis AG Clinical-Stage Biopharmaceutical Definitive Moratorium Status Basel-Landschaft West Court Macrocycle Therapeutics
BRIEF

published on 07/22/2024 at 07:20, 3 months 30 days ago

Spexis Provides Updates on Financial Audit, Moratorium, and Executive Changes

Executive Changes Financial Audit Biopharmaceutical Spexis Moratorium
PRESS RELEASE

published on 07/22/2024 at 07:15, 3 months 30 days ago

Spexis expects that audit of its 2023 financials will not be completed by 31 July 2024, provides status update relating to the Company’s moratorium and changes to its Executive Committee.
Spexis AG announces delay in audit of 2023 financials, updates on moratorium status & Executive Committee changes. Will expect temporary trading suspension by SIX

Spexis AG Trading Suspension Audit Delay Moratorium Status Executive Committee Changes
BRIEF

published on 07/08/2024 at 07:20, 4 months 13 days ago

Spexis AG: PARI Pharma GmbH Announces Termination of ColiFin® License to EnBiotix, Inc.

Spexis AG PARI Pharma ColiFin® EnBiotix, Inc. Debt-restructuring
PRESS RELEASE

published on 07/08/2024 at 07:15, 4 months 13 days ago

Spexis AG: PARI Pharma GmbH announces termination of ColiFin® license to EnBiotix, Inc.
PARI Pharma GmbH terminates ColiFin® license to EnBiotix, Inc. Spexis AG deals with debt-restructuring amid license termination

Spexis AG ColiFin® Debt-restructuring PARI Pharma GmbH License Termination
BRIEF

published on 06/04/2024 at 20:05, 5 months 16 days ago

Spexis Appeals Suspension of its Shares on SIX Exchange

Annual Report Spexis AG Appeal SIX Exchange Shares Suspension
PRESS RELEASE

published on 06/04/2024 at 20:00, 5 months 16 days ago

Spexis launches appeal against SIX Exchange Regulation decision to suspend trading of its shares.
Spexis AG launches appeal against trading suspension decision by SIX Exchange Regulation regarding its shares due to audit report publication delay

Spexis AG SIX Exchange Regulation Trading Suspension Audit Report Shareholder Appeal

1 2 ... 4

Accesswire

Published on 11/21/2024 at 13:00, 28 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 28 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 28 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 28 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 28 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 13 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 53 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 13 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 21 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 28 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 30 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 8 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 43 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 43 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE